TNXP | Woo Trader

CTNXP - Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Last Close	$3.60^+2.86%	Range	$3.50-$3.68
Volume	39,700^-43%	Market Cap	$28.19 M
Avg Daily $	$251,813	Avg Volume	69,948
52 Week High	$9.40^-62%	52 Week Low	$0.33^+991%
Insider Score	No Activity	%Insiders	4%
%Institutions	19.51%	%M.F.	2.7%
Price Target	N/A	Mean Rating	Outperform
Zacks Target	$9.50^+164%	Zacks Rating	Strong Buy
TR Target	N/A	TR Rating	N/A
News/Blogs	N/A	With Impact	N/A
Next Earnings	2018-04-16	Forward EPS	‑$0.77
EPS	-2.82	P/E	-1.28
Dividend	N/A	Yield	N/A

Wootrader.com is moving to https://financeboards.com - sign up for a free account.

CTNXP - Tonix Pharmaceuticals Holding Corp.

This full content is available for membership level Budding Investor or higher. You can register for a new account now.